Trevor Phillips

Directeur/Membre du Conseil chez Imutex Ltd.

Profil

Trevor Michael Phillips currently works at Imutex Ltd., as Director from 2018.
Dr. Phillips also formerly worked at Cornerstone Therapeutics, Inc., as President & Chief Executive Officer, hVIVO PLC, as Chief Executive Officer in 2020, Critical Therapeutics, Inc., as President & Chief Executive Officer in 2008, hVIVO Holdings Ltd., as Executive Chairman from 2017 to 2020, NEPeSMO Ltd., as Chairman from 2007 to 2023, Sumitomo Pharma America, Inc., as Senior Program Director from 2001 to 2002, Glaxo Wellcome Plc, as Director-Strategic Direction from 1990 to 1997, Vectura Group Ltd., as Executive Director in 2017, Scotia Holdings Plc, as Director-Drug Development, Strategy & Planning from 1999 to 2001, Morvus Technology Ltd., as Non-Executive Director, Vectura GmbH, as Chief Operations Officer & Director, hVIVO Services Ltd., as Non-Executive Director in 2017, Tissue Regenix Group Plc, as Independent Non-Executive Director from 2021 to 2025, Accenture Ltd., as Senior Manager-Strategic Planning from 1997 to 1999, and Simbec Research Ltd., as Head-Research & Development.
Dr. Phillips received his undergraduate degree from The University of Reading, doctorate degree in 1986 from the University of Wales (Bangor), Masters Business Admin degree from Henley Management College, and doctorate degree from Swansea University.

Postes actifs de Trevor Phillips

Sociétés	Poste	Début
Imutex Ltd.	Directeur/Membre du Conseil	27/04/2018

Anciens postes connus de Trevor Phillips

Sociétés	Poste	Fin
TISSUE REGENIX GROUP LTD	Directeur/Membre du Conseil	08/09/2025
NEPeSMO Ltd.	Président	01/01/2023
HVIVO PLC	Directeur Général	01/06/2020
HVIVO PLC	Président	01/01/2020
VECTURA GROUP	Directeur des opérations	25/05/2017